GI Dynamics is leading the field of nonsurgical therapeutics to treat type 2 diabetes and obesity - metabolic conditions that affect millions of people worldwide.
The EndoBarrierTM Gastrointestinal Liner may be the ideal treatment for patients with both type 2 diabetes and obesity. It works by creating a physical barrier between food that has been ingested and the intestinal wall. The EndoBarrier Gastrointestinal Liner is placed endoscopically (via the mouth) in a simple, brief procedure and is easily removed.
Hundreds of patients have been treated with the EndoBarrier System in clinical trials in South America, Europe, and the US.
